Neil Akhurst - Profile and Investment Details
Find investors who align with your industry, stage, and vision. Unlock Neil Akhurst’s full investment profile, including location, investment focus, portfolio companies, and preferences. Sign up today and start building investor relationships that fuel your startup’s growth.
Get connected with all investors today
- Health Care,
- Wearables,
- High-growth Startups,
- Wellness,
- Women Founded,
- Fundraising,
- Investment Management,
- HR Tech,
- Android,
- Healthcare Innovation,
- Life Science,
- Portfolio Management,
- Medical Technologies,
- Analytics,
- Venture Fundraising,
- Finance,
- Intellectual Property,
- Manufacturing,
- Biotechnology,
- Medical Devices,
- Hardware,
- Logistics,
- Health Diagnostics,
- Digital Health,
- Developer Tools,
- Medical,
- Information Technology,
- B2B,
- Media and Entertainment,
- Pharmaceuticals,
- Healthcare Technology
Social media:
Past investments:
- Vantia Therapeutics
- Spherics
- Onbone
- Zipline Medical
- Solx
- Oxxon Therapeutics
- Horizon Discovery
- Clavis Pharma
- Tarsa Therapeutics
- GT Medical Technologies
- Cara Therapeutics
- SkyCell
- Heptares Therapeutics
- Providence Medical Technology
- Vertos Medical
- Serentis
- Cheetah Medical
- Biotheranostics
- BioVex
- De Novo Pharmaceuticals
- Patient Connect
- BioXell
- Wilson Therapeutics
- eXmoor Pharma
- PregLem
- Aegerion Pharmaceuticals
- AmbioPharm
- Lombard Medical plc
- Momenta Pharmaceuticals
- Evotec Neurosciences
- VitalConnect
- Avantium Technologies
- Xention
- Paragon 28
- eZono
- Beacon Endoscopic
- Vascular Pathways
- MDxHealth
- AccuVein
Investor Profile
Neil Akhurst is a Venture Capital, Private Equity Firm, Investment Partner based in Greater London, England, United Kingdom with a diverse investment portfolio that includes companies such as Vantia Therapeutics, Spherics, OnboneZipline Medical, Solx, Oxxon Therapeutics, Horizon Discovery, Clavis Pharma, Tarsa Therapeutics, GT Medical Technologies, Cara Therapeutics, SkyCell, Heptares Therapeutics, Providence Medical Technology, Vertos Medical, Serentis, Cheetah Medical, Biotheranostics, BioVex, De Novo Pharmaceuticals, Patient Connect, BioXell, Wilson Therapeutics, eXmoor Pharma, PregLem, Aegerion Pharmaceuticals, AmbioPharm, Lombard Medical plc, Momenta Pharmaceuticals, Evotec Neurosciences, VitalConnect, Avantium Technologies, Xention, Paragon 28, eZono, Beacon Endoscopic, Vascular Pathways, MDxHealth, AccuVein, . Over time, Neil Akhurst has demonstrated experience in supporting a range of businesses across various sectors.
While it is not publicly confirmed whether Neil Akhurst is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.
Startups and entrepreneurs operating in sectors related to Health Care, Wearables, High-growth Startups, Wellness, Women Founded, Fundraising, Investment Management, HR Tech, Android, Healthcare Innovation, Life Science, Portfolio Management, Medical Technologies, Analytics, Venture Fundraising, Finance, Intellectual Property, Manufacturing, Biotechnology, Medical Devices, Hardware, Logistics, Health Diagnostics, Digital Health, Developer Tools, Medical, Information Technology, B2B, Media and Entertainment, Pharmaceuticals, Healthcare Technology may find it worthwhile to explore potential connections with Neil Akhurst, as their portfolio suggests a familiarity and interest in this area.
Understanding Neil Akhurst’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.
Angel Match is the easiest way to research investors for your startup so you can spend less time Googling and more time raising.
Find the perfect investors today
